[1]史晓林,杨依然,刘钟,等.基于蛋白质组学方法分析绝经后骨质疏松症全血差异蛋白[J].中医正骨,2019,31(06):7-11.
 SHI Xiaolin,YANG Yiran,LIU Zhong,et al.Analysis of proteins which are differentially expressed in whole blood of patients with postmenopausal osteoporosis using proteomics approach[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2019,31(06):7-11.
点击复制

基于蛋白质组学方法分析绝经后骨质疏松症全血差异蛋白()
分享到:

《中医正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第31卷
期数:
2019年06期
页码:
7-11
栏目:
临床研究
出版日期:
2019-06-20

文章信息/Info

Title:
Analysis of proteins which are differentially expressed in whole blood of patients with postmenopausal osteoporosis using proteomics approach
作者:
史晓林1杨依然2刘钟2李春雯3梁博程1刘康1何伟涛4胡炯1
(1.浙江中医药大学附属第二医院,浙江 杭州 310005; 2.浙江中医药大学第二临床医学院,浙江 杭州 310053; 3.浙江中医药大学基础医学院,浙江 杭州 310053; 4.海盐县中医院,浙江 海盐 314300)
Author(s):
SHI Xiaolin1YANG Yiran2LIU Zhong2LI Chunwen3LIANG Bocheng1LIU Kang1HE Weitao4HU Jiong1
1.The Second Affiliated Hospital of Zhejiang Chinese Medical University,Hangzhou 310005,Zhejiang,China; 2.The Second Clinical Medical College of Zhejiang Chinese Medical University,Hangzhou 310053,Zhejiang,China; 3.The basic Medical College of Zhejiang Chinese Medical University,Hangzhou 310053,Zhejiang,China; 4.Traditional Chinese Medical Hospital of Haiyan county,Haiyan 314300,Zhejiang,China
关键词:
骨质疏松绝经后 蛋白质组学 色谱法 高压液相 串联质谱法 差异蛋白
Keywords:
osteoporosispostmenopausal proteomics chromatographyhigh pressure liquid tandem mass spectrometry differentially expressed protein
摘要:
目的:基于蛋白质组学方法筛选绝经后骨质疏松症(postmenopausal osteoporosis,PMOP)全血差异蛋白。方法:选择7例PMOP患者(骨质疏松组)和7例绝经后骨量正常女性(骨量正常组)作为研究对象。空腹抽取静脉血,采用高效液相色谱-串联质谱技术筛选PMOP全血差异蛋白,选取其中发生显著变化的差异蛋白进行生物信息学分析。结果:①差异蛋白鉴定及筛选结果。应用高效液相色谱-串联质谱技术共定量检测到102个PMOP差异蛋白质,其中25个蛋白质位点表达上调、77个蛋白质位点表达下调。68个蛋白质两组差异倍数超过2.0,其中39个蛋白质两组差异倍数有统计学意义(P<0.01)。②生物信息学分析结果。基因功能注释发现,差异蛋白主要参与的细胞活动为单一生物过程、细胞代谢过程、细胞生物调节、对刺激和代谢过程的反应,主要的分子功能为催化活性和结构分子活动。亚细胞定位分析发现,102个差异蛋白质中,位点表达上调的25个差异蛋白全部位于细胞内,位点表达下调的77个差异蛋白中,19个在细胞外,其他均在细胞内。39个目标差异蛋白相互作用网络图显示,蛋白酶体亚基α型-7(proteasome subunit alpha type-7,PSMA7)、蛋白酶体亚基β型-7(proteasome subunit beta type-7,PSMB7)、蛋白酶体亚基β型-3(proteasome subunit beta type-3,PSMB3)、蛋白酶体亚基α型-1(proteasome subunit alpha type-1,PSMA1)、神经前体细胞表达发育下调因子8(neural precursor cell-expressed developmentally downregulated 8,NEDD8)、DNA损伤结合蛋白1(DNA damage-binding protein 1,DDB1)、RAD23A、UBA52等蛋白位于相互作用网络节点的中心。结论:以全血作为样本采用蛋白质组学方法可筛选出数量丰富的PMOP差异蛋白,其中PSMA7、PSMB7、PSMB3、PSMA1、NEDD8、DDB1、RAD23A、UBA52可能是PMOP的潜在有效血液标志物。
Abstract:
Objective:To select the proteins which are differentially expressed in whole blood of patients with postmenopausal osteoporosis(PMOP)using proteomics approach.Methods:Seven females with PMOP(osteoporosis group)and seven postmenopausal females with normal bone mass(normal bone mass group)were selected out as the subjects.The fasting blood were fetched out from vein.The proteins which were differentially expressed in whole blood of patients with PMOP were selected out by using high pressure liquid chromatography-tandem mass spectrometry(HPLC-MS/MS),and those proteins which were obviously differentially expressed in whole blood were picked out for further bioinformatic analysis.Results:A total of 102 differentially expressed proteins were found out by HPLC-MS/MS,in which the expressions of 25 protein loci were up-regulated and the expressions of 77 protein loci were down-regulated.The fold change of 68 proteins exceeded 2.0,while there was statistical significance in fold change of 39 out of 68 proteins(P<0.01).The results of gene annotation demonstrated that the differentially expressed proteins were mainly involved in 4 kinds of cell activities,including single biological process,cell metabolism process,cell biological regulation and response to stimulation and metabolism process,and their main molecular functions included catalytic activities and structural molecular activities.The results of subcellular positioning analysis demonstrated that 25 differentially expressed proteins with up-regulated loci expressions were inside the cells,and out of 77 differentially expressed proteins with down-regulated loci expressions 19 were outside the cells and the others were inside the cells.The network diagram of interaction between 39 differentially expressed proteins showed that proteasome subunit alpha type-7(PSMA7),proteasome subunit beta type-7(PSMB7),proteasome subunit beta type-3(PSMB3),proteasome subunit alpha type-1(PSMA1),neural precursor cell-expressed developmentally downregulated 8(NEDD8),DNA damage-binding protein 1(DDB1),RAD23A and UBA52 were located at the center of the interaction network nodes.Conclusion:Abundant differentially expressed proteins of PMOP in whole blood can be identified using proteomics approach,and PSMA7,PSMB7,PSMB3,PSMA1,NEDD8,DDB1,RAD23A and UBA52 may be the potential effective blood markers of PMOP.

参考文献/References:

[1] 欧国峰,刘鑫,董博,等.绝经后骨质疏松症的免疫学研究进展[J].中医正骨,2016,28(8):70-72. [2] 刘晨,李兴勇,姚兴璋,等.绝经后骨质疏松症的流行病学概况及发病机制研究进展[J].中医正骨,2018,30(3):52-55. [3] SONG C,WANG J,KIM B,et al.Insights into the role of circadian rhythms in bone metabolism:a promising intervention target?[J/OL].Biomed Res Int,2018[2019-01-15].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180976. [4] CANO A,GARCÍA-PÉREZ MÁ.Menopause[M].Cham:Springer,1997:129. [5] 中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南(2017)[J].中华骨质疏松和骨矿盐疾病杂志,2017,10(5):413-444. [6] 綦丹丹.硅对镉胁迫欧美杨无性系I-214酶活性及蛋白质组的影响[D].沈阳:沈阳农业大学,2017. [7] NIELSON C M,WIEDRICK J,SHEN J,et al.Identification of hip BMD loss and fracture risk markers through Population-Based serum proteomics[J].J Bone Miner Res,2017,32(7):1559-1567. [8] XIE Y,GAO Y,ZHANG L,et al.Involvement of serum-derived exosomes of elderly patients with bone loss in failure of bone remodeling via alteration of exosomal bone-related proteins[J].Aging Cell,2018,17(3):e12758. [9] ZHANG L,LIU Y Z,ZENG Y,et al.Network-based proteomic analysis for postmenopausal osteoporosis in Caucasian females[J].Proteomics,2016,16(1):12-28. [10] QUNDOS U,DROBIN K,MATTSSON C,et al.Affinity proteomics discovers decreased levels of AMFR in plasma from osteoporosis patients[J].Proteomics Clin Appl,2016,10(6):681-690. [11] LIM J,HWANG S.Identification of Osteoporosis-Associated protein biomarkers from ovariectomized rat urine[J].Curr Proteomics,2017,14(2):130-137. [12] ZHOU Q,XIE F,ZHOU B,et al.Differentially expressed proteins identified by TMT proteomics analysis in bone marrow microenvironment of osteoporotic patients[J].Osteoporos Int,2019,30(5):1089-1098. [13] ZOU J,MA W,LI J,et al.Neddylation mediates ventricular chamber maturation through repression of Hippo signaling[J].Proc Natl Acad Sci U S A,2018,115(17):E4101-E4110. [14] YANG W,HAN W,QIN A,et al.The emerging role of Hippo signaling pathway in regulating osteoclast formation[J].J Cell Physiol,2018,233(6):4606-4617. [15] SUN L,PAN X,WADA J,et al.Isolation and functional analysis of mouse UbA52 gene and its relevance to diabetic nephropathy[J].J Biol Chem,2002,277(33):29953-29962. [16] 张艳,任荣,张蕾.早期糖尿病肾病患者血糖、肾小球率过滤、NAG酶与尿UBA52的关系研究[J].新疆医科大学学报,2014,37(7):887-890. [17] 杨旭升,张蕾.泛素-核糖体融合蛋白52——糖尿病肾病的早期生物标志物[J].肾脏病与透析肾移植杂志,2014,23(2):176-178. [18] ABBASZADEH H A,PEYVANDI A A,SADEGHI Y,et al.Er:YAG laser and cyclosporin a effect on cell cycle regulation of human gingival fibroblast cells[J].J Lasers Med Sci,2017,8(3):143-149. [19] BUDNY B,SZCZEPANEK-PARULSKA E,ZEMOJTEL T,et al.Mutations in proteasome-related genes are associated with thyroid hemiagenesis[J].Endocrine,2017,56(2):279-285.

相似文献/References:

[1]李林军.应用膨胀式椎弓根螺钉内固定治疗合并骨质疏松的 胸腰椎退行性疾病[J].中医正骨,2015,27(08):49.
[2]李学朋,朱立国.骨疏康胶囊对去卵巢大鼠骨小梁的影响[J].中医正骨,2015,27(12):12.
 LI Xuepeng,ZHU Liguo.Effect of Gushukang Jiaonang(骨疏康胶囊)on bone trabecula in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(06):12.
[3]陈冠军,陈扬,庄汝杰.可灌注骨水泥椎弓根螺钉系统 在老年腰椎疾患手术中的应用[J].中医正骨,2015,27(02):40.
[4]王丹辉,贲越,韩梅.林蛙油治疗绝经后骨质疏松症的临床研究[J].中医正骨,2014,26(01):27.
 Wang Danhui*,Ben Yue,Han Mei..Clinical study of Rana temporaria oil in the treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(06):27.
[5]黄建华,黄建武,李慧辉,等.加味左归丸对绝经后骨质疏松症肝肾不足证 患者骨密度的影响[J].中医正骨,2013,25(11):19.
 Huang Jianhua*,Huang Jianwu,Li Huihui,et al.Effect of JIAWEI ZUOGUI pill on bone mineral density in postmenopausal osteoporosis patients with deficiency of liver and kidney[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(06):19.
[6]项旻,杨虹,林爱菊,等.绝经后2型糖尿病患者骨质疏松与血微量元素的关系研究[J].中医正骨,2013,25(12):20.
 Xiang Min*,Yang Hong,Lin Aiju,et al.Clinical study on the relationship between osteoporosis and serum trace elements levels in postmenopausal women with type 2 diabetes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(06):20.
[7]史晓林,李春雯,张志强.弱阳离子磁珠分离技术和基质辅助激光解吸电离飞行时间质谱技术在原发性Ⅰ型骨质疏松症血清标志蛋白筛选中的应用[J].中医正骨,2014,26(03):5.
 Shi Xiaolin*,Li Chunwen,Zhang Zhiqiang..Application of magnetic beads based weak cation exchange separation technology and matrix-assisted laser desorption-ionization time of flight mass spectrometry technology in screening serum protein markers of primary type-Ⅰ osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(06):5.
[8]李明,徐明雄,冯左基,等.自拟壮骨方治疗绝经后骨质疏松症的疗效及作用机制研究[J].中医正骨,2014,26(09):21.
 Li Ming*,Xu Mingxiong,Feng Zuoji,et al.Study on the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(06):21.
[9]陈俊杰,李晴晴,夏瑢.脂代谢及血清内脂素水平与绝经后骨质疏松症的 相关性研究[J].中医正骨,2012,24(04):16.
 CHEN Jun-jie*,LI Qing-qing,XIA Rong.*.Study on the correlations between the levels of lipid metabolism and serum visfatin and postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(06):16.
[10]许超,肖鲁伟,吴承亮.绝经后女性骨质疏松症辨证分型与抑郁焦虑的关系研究[J].中医正骨,2011,23(12):3.
 XU Chao*,XIAO Lu-wei,WU Cheng-liang.*.Study on the relationship between the syndrome differ classification and the depression and anxiety for the postmenopausal women with osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2011,23(06):3.
[11]韩艳,温利平,刘娜,等.补肾活血方对去卵巢大鼠骨代谢及骨密度的影响[J].中医正骨,2015,27(12):7.
 HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(补肾活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(06):7.
[12]欧国峰,刘鑫,董博,等.绝经后骨质疏松症的免疫学研究进展[J].中医正骨,2016,28(08):70.
[13]施振宇,刘钟,陈文亮,等.中医综合疗法防治绝经后骨量减少的多中心临床研究[J].中医正骨,2017,29(04):1.
 SHI Zhenyu,LIU Zhong,CHEN Wenliang,et al.A multicenter clinical study of complex therapy of traditional Chinese medicine for prevention and treatment of postmenopausal osteopenia[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(06):1.
[14]梁文娜,李西海,李灿东.血清microRNA与绝经后骨质疏松症肾虚证的关系[J].中医正骨,2017,29(10):53.
[15]梁文娜,李西海,胡柳,等.二至丸抑制绝经后骨质疏松大鼠骨代谢紊乱的作用机制研究[J].中医正骨,2017,29(11):1.
 LIANG Wenna,LI Xihai,HU Liu,et al.Study on mechanism of action of Erzhi Wan(二至丸)in inhibiting bone metabolism disorder in rats with postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(06):1.
[16]刘晨,李兴勇,姚兴璋,等.绝经后骨质疏松症的流行病学概况及发病机制研究进展[J].中医正骨,2018,30(03):52.
[17]杨依然,刘钟,毛一凡,等.酪蛋白激酶-2相互作用蛋白1基于磷脂酰肌醇3-激酶/蛋白激酶B/哺乳动物雷帕霉素靶蛋白通路参与绝经后骨质疏松症发生发展过程中细胞自噬的机制[J].中医正骨,2018,30(04):59.
[18]曹俊青,郑剑南,张麟.右归丸联合阿仑膦酸钠口服治疗绝经后骨质疏松症肾阳虚证的临床研究[J].中医正骨,2018,30(05):20.
 CAO Junqing,ZHENG Jiannan,ZHANG Lin.A clinical study of oral application of Yougui Wan(右归丸)and alendronate sodium for treatment of postmenopausal osteoporosis with kidney-yang deficiency syndrome[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(06):20.
[19]李中万,徐绍俊,杨广钢,等.健肾方联合碳酸钙D3咀嚼片(Ⅱ) 治疗绝经后骨质疏松症肾阳虚证[J].中医正骨,2018,30(08):11.
 LI Zhongwan,XU Shaojun,YANG Guanggang,et al.Oral application of Jianshen Fang(健肾方)and calcium carbonate and Vitamin D3 chewable tablets(Ⅱ)for treatment of postmenopausal osteoporosis with kidney-yang deficiency syndrome[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(06):11.
[20]赵凡,刘全,吴连国.口服强骨饮联合碳酸钙D3片治疗绝经后骨质疏松症的临床研究[J].中医正骨,2019,31(04):26.
 ZHAO Fan,LIU Quan,WU Lianguo.Oral applications of Qianggu Yin(强骨饮)and calcium carbonate and Vitamin D3 tablets for treatment of postmenopausal osteoporosis:a clinical study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2019,31(06):26.

备注/Memo

备注/Memo:
基金项目:国家自然科学基金项目(81573754; 81873129); “十三五”浙江省中医药(中西医结合)重点学科建设计划项目(2017-XK-A16) 通讯作者:史晓林 E-mail:xlshi-2002@163.com(收稿日期:2019-04-06 本文编辑:李晓乐)
更新日期/Last Update: 1900-01-01